Tahupis, Lourdes .

HRN: 16-49-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 500MG (TAB)
08/18/2023
08/24/2023
ORAL
500mg
BID
Thickly MSAF
Waiting Final Action 
08/18/2023
METRONIDAZOLE 500MG (TAB)
08/18/2023
08/24/2023
ORAL
500mg
Tid
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: